6 completed, 1 active not recruiting, 1 unknown. 8 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 6, Active not recruiting 1, Unknown 1 |
Follow Cholestyramine Resin: new trials by email Literature Review of Cholestyramine Resin trials Research Report on Cholestyramine Resin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis Frexalimab, Teriflunomide, Placebo infusion - Multiple Sclerosis | Phase 3 | Active not recruiting | Sanofi | 1655 | 2023-12-13 | 2026-07-20 |
| An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia Alirocumab SAR236553 (REGN727), Atorvastatin, Simvastatin - Hypercholesterolemia | Phase 3 | Completed | Sanofi | 18 | 2018-08-31 | 2020-12-29 |
| An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia Alirocumab SAR236553 (REGN727), Rosuvastatin, Atorvastatin - Hypercholesterolaemia | Phase 3 | Completed | Sanofi | 153 | 2018-05-31 | 2023-05-06 |
| Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt Hyperthyroidism Cholestyramine Powder 4g, Prednisolone, Standard treatment - Hyperthyroidism, Graves Disease | Phase 3 | Unknown | Clinical Research Centre, Malaysia | 135 | 2017-05-11 | 2017-10-05 |
| Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple Sclerosis teriflunomide HMR1726, cholestyramine, charcoal - Multiple Sclerosis | Phase 3 | Completed | Sanofi | 70 | 2013-10-01 | 2015-03-13 |
| Post Coronary Artery Bypass Graft (CABG) Study lovastatin, cholestyramine, warfarin - Cardiovascular Diseases, Coronary Disease | Phase 3 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1987-04-01 | 2016-04-14 | |
| Lipid Research Clinics Coronary Primary Prevention Trial (CPPT) cholestyramine, diet, fat-restricted - Cardiovascular Diseases, Coronary Disease | Phase 3 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1973-06-01 | 2016-04-14 | |
| NHLBI Type II Coronary Intervention Study cholestyramine - Cardiovascular Diseases, Coronary Disease | Phase 3 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1971-11-01 | 2012-04-27 |
Cardiovascular Diseases (3) · Coronary Disease (3) · Heart Diseases (3) · Myocardial Ischemia (3) · Hypercholesterolemia (2) · Multiple Sclerosis (2) · Graves Disease (1) · Homozygous Familial Hypercholesterolemia (1) · Hyperlipoproteinemia Type II (1) · Hyperthyroidism (1) · Myocardial Infarction (1)
Sanofi (4) · National Heart, Lung, and Blood Institute (NHLBI) (3) · Clinical Research Centre, Malaysia (1)
Brazil (3) · Canada (3) · Denmark (3) · Mexico (3) · Netherlands (3) · Spain (3) · Taiwan (3) · Turkey (Türkiye) (3) · Argentina (2) · Austria (2) · Belgium (2) · Bulgaria (2) · Czechia (2) · France (2) · Germany (2)
Anne Goldberg (1) · Dennis Sprecher (1) · Elizabeth Barrett-Connor (1) · Francois Abboud (1) · Frank Ibbott (1) · Genell Knatterud (1) · Gerald Cooper (1) · Ivan Frantz (1) · J. Little (1) · John Brensike (1) · John Farquhar (1) · John LaRosa (1) · L. Sheffield (1) · Marilyn Buzzard (1)
PMID 32414298, PMID 36325897, PMID 38315470, PMID 39899371
2017 (2), 2023 (1)